NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email More than a dozen Western countries, including US, U.K., issue joint statement calling out Iranian intelligence services for targeting citizens in assassination and kidnapping plots.Read More